Corpus Intelligence IC Memo — WATERTOWN REGIONAL MEDICAL CENTER 2026-04-26 10:39 UTC
IC Memo — WATERTOWN REGIONAL MEDICAL CENTER
Investment Committee Memorandum | WI | 76 beds | Grade C | EBITDA uplift $7.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WATERTOWN REGIONAL MEDICAL CENTER

CCN 520116 | DODGE, WI | 76 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WATERTOWN REGIONAL MEDICAL CENTER is a 76-bed under-performing / distressed in DODGE, WI with $102.4M in net patient revenue and a -21.4% operating margin. The hospital serves a payer mix of 36.3% Medicare, 4.8% Medicaid, and 58.8% commercial.

Thesis: Turnaround. Our ML models identify $7.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.4% to -14.1% (+736bps).

Net Revenue HCRIS$102.4M
Current EBITDA COMPUTED$-21.9M
Operating Margin COMPUTED-21.4%
Occupancy HCRIS23.2%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS32.5%
Distress Probability ML54.9%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
46
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -21.4% places it below the state median. Among 46 size-comparable peers (38-152 beds), the median margin is -4.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-152), prioritizing same-state peers. 46 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WATERTOWN REGIONAL MEDICAL CEN (Target)WI76$102.4M-21.4%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
MCHS FRANCISCAN HEALTHCARE INWI103$413.8M-7.2%
AURORA MEDICAL CENTER KENOSHAWI151$304.2M13.8%
AURORA MEDICAL CENTER GRAFTONWI132$300.4M16.7%
ST. AGNES HOSPITALWI77$275.9M-3.0%
BELOIT MEMORIAL HOSPITAL INC.WI97$249.6M-3.0%
THEDACARE REGIONAL MEDICAL CENWI139$247.3M5.1%
AURORA MEDICAL CENTER OF OSHKOWI79$222.3M17.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.1M+210bp18mo
Cost to Collect4.5%2.5%$2.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.2M+122bp9mo
Clean Claim Rate88.0%96.0%$66K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.1M
Cost to Collect
$2.0M
Denial Rate Reduction
$2.0M
A/R Days Reduction
$1.2M
Clean Claim Rate
$66K
Total EBITDA Uplift$7.5M
Current EBITDA$-21.9M
+ RCM Uplift+$7.5M
Pro Forma EBITDA$-14.4M
Current Margin-21.4%
Pro Forma Margin-14.1%
WC Released (1x)$3.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-33.7M$-69.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-33.7M$-87.1M0.00x-100.0%
Bull Case9.0x11.0x$-30.3M$-73.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-30.3M$-88.8M0.00x-100.0%
Bear Case11.0x10.0x$-37.1M$-96.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-37.1M$-117.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 23.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 46 hospitals with 38-152 beds
  • Same-state prioritization (n=47)
  • Comp margins: P25=-12.7% / P50=-4.4% / P75=13.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.